Erin Denny has extensive experience in oncology business development, currently serving as Executive Director at Amgen since May 2015, having previously held roles as Director and Licensing Senior Manager within the same organization. Denny is also active in the Association for Women in Science, contributing as Chapter Advisor and Co-President since April 2015. Prior to Amgen, Denny worked as a Graduate Researcher at City of Hope, focusing on a thesis about t-Darpp's role in trastuzumab resistance under the guidance of Principal Investigator Susan Kane, Ph.D. Educational qualifications include a Ph.D. in Biological and Biomedical Sciences from Irell & Manella Graduate School and a B.S. in Biology with a Biotechnology Minor from the University of Southern California. Early research experiences include internships at Theraptosis and the National Institutes of Health.
Org chart
This person is not in the org chart
Teams
This person is not in any teams
Offices
Amgen
253 followers
Amgen is committed to unlocking the potential of biology for patients suffering from serious illnesses by discovering, developing, manufacturing and delivering innovative human therapeutics. This approach begins by using tools like advanced human genetics to unravel the complexities of disease and understand the fundamentals of human biology.
